magea10
Share
  • Official Full Name
  • melanoma antigen family A, 10
  • Background
  • This gene is a member of the MAGEA gene family. The members of this family encode proteins with 50 to 80% sequence identity to each other. The promoters and first exons of the MAGEA genes show considerable variability, suggesting that the existence of this gene family enables the same function to be expressed under different transcriptional controls. The MAGEA genes are clustered at chromosomal location Xq28. They have been implicated in some hereditary disorders, such as dyskeratosis congenita. Alternative splicing results in multiple transcript variants. Read-through transcription also exists between this gene and the downstream melanoma antigen family A, 5 (MAGEA5) gene.
  • Synonyms
  • MAGEA10; melanoma antigen family A, 10; MAGE10; melanoma-associated antigen 10; cancer/testis antigen family 1; member 10; CT1.10; MAGE 10 antigen; melanoma associated antigen 10; MGC10599; MAGE-10 antigen; cancer/testis antigen 1.10; cancer/testis antige
Cat.#:MAGEA10-2231HTag:His
Source (Host):YeastSpecies:Human
Product nameRecombinant Human MAGEA10 Protein (1-369 aa), His-tagged
+Inquiry
Cat.#:MAGEA10-689HTag:GST
Source (Host):E. coliSpecies:Human
Product nameRecombinant Human MAGEA10, GST-tagged
+Inquiry
Cat.#:MAGEA10-2125HCLTag:N/A
Source (Host):Species:Human
Product nameRecombinant Human MAGEA10 cell lysate
+Inquiry

Interacting Protein

MAGEA10 has direct interactions with proteins and molecules. Those interactions were detected by several methods such as yeast two hybrid, co-IP, pull-down and so on. We selected proteins and molecules interacted with MAGEA10 here. Most of them are supplied by our site. Hope this information will be useful for your research of MAGEA10.
PON2; XPO1; SCO2; NCOA2; QSER1; FAM216A; KAT2A; FOXJ2; SLAIN2; MTUS1; MTCL1

MAGEA10 Related Articles

Uzdensky, A; Demyanenko, S; et al. Expression of proteins involved in epigenetic regulation in human cutaneous melanoma and peritumoral skin. TUMOR BIOLOGY 35:8225-8233(2014).
Smethurst, D; et al. A pharmacologic perspective on newly emerging T-cell manipulation technologies. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 76:173-187(2013).